Diabetic Retinopathy Detection: AI Models and Approaches.

IF 1.9 4区 医学 Q3 OPHTHALMOLOGY
Journal of Ophthalmology Pub Date : 2026-04-26 eCollection Date: 2026-01-01 DOI:10.1155/joph/8857887
Meftah Mohamed Mohamed Madi, Peter Clarke- Farr, Dirk Bester
{"title":"Diabetic Retinopathy Detection: AI Models and Approaches.","authors":"Meftah Mohamed Mohamed Madi, Peter Clarke- Farr, Dirk Bester","doi":"10.1155/joph/8857887","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Diabetic retinopathy (DR), a major cause of vision loss worldwide, results from chronic diabetes damage to retinal blood vessels. Vision loss can be prevented if DR is detected early, but traditional retinal screening by eye care takes time and expertise. Recent advances in AI technology, including classical machine learning and deep learning, can be more accurate in DR detection. This article provides a comprehensive review of current AI models and approaches of DR screening.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science, Scopus, ScienceDirect, and EBSCOhost using the keywords: diabetes, retinopathy, screening, and early detection. The search was limited to English language and studies published between 2020 and 2025.</p><p><strong>Results: </strong>The findings suggest that AI models have become crucial for early DR diagnosis. While traditional machine learning previously lacked effectiveness, deep learning has now significantly improved diagnostic performance. The models, such as the URNet system, the vision transformer (ViT) model, the ResNet-50 and EfficientNetB0 models, the DenseNet model, and the ResNet-18 model, have achieved high-performance metrics using publicly available datasets. DR screening devices, like ADX-DR, have shown commendable performance. The EyeArt modality demonstrated exceptional sensitivity across diverse populations, detecting around 98.5% of vision-threatening DR, while Google AI matched specialist performance in specificity and surpassed it in sensitivity.</p><p><strong>Conclusion: </strong>AI methods using deep learning frameworks such as CNNs have attained expert-level accuracy in DR classification, in addition to real-world validation. Semiautonomous systems like the IDx-DR and EyeArt have robust clinical performance and scalability, especially in countries with few ophthalmologists. Although research has been mainly conducted in Asia, there is a lack of research from Africa and low-income countries. Future techniques, including ensemble models and federated learning, will enhance accuracy and reliability further, aiding early diagnosis and prevention of vision loss globally.</p>","PeriodicalId":16674,"journal":{"name":"Journal of Ophthalmology","volume":"2026 ","pages":"8857887"},"PeriodicalIF":1.9000,"publicationDate":"2026-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13110411/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/joph/8857887","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Diabetic retinopathy (DR), a major cause of vision loss worldwide, results from chronic diabetes damage to retinal blood vessels. Vision loss can be prevented if DR is detected early, but traditional retinal screening by eye care takes time and expertise. Recent advances in AI technology, including classical machine learning and deep learning, can be more accurate in DR detection. This article provides a comprehensive review of current AI models and approaches of DR screening.

Methods: We searched PubMed, Web of Science, Scopus, ScienceDirect, and EBSCOhost using the keywords: diabetes, retinopathy, screening, and early detection. The search was limited to English language and studies published between 2020 and 2025.

Results: The findings suggest that AI models have become crucial for early DR diagnosis. While traditional machine learning previously lacked effectiveness, deep learning has now significantly improved diagnostic performance. The models, such as the URNet system, the vision transformer (ViT) model, the ResNet-50 and EfficientNetB0 models, the DenseNet model, and the ResNet-18 model, have achieved high-performance metrics using publicly available datasets. DR screening devices, like ADX-DR, have shown commendable performance. The EyeArt modality demonstrated exceptional sensitivity across diverse populations, detecting around 98.5% of vision-threatening DR, while Google AI matched specialist performance in specificity and surpassed it in sensitivity.

Conclusion: AI methods using deep learning frameworks such as CNNs have attained expert-level accuracy in DR classification, in addition to real-world validation. Semiautonomous systems like the IDx-DR and EyeArt have robust clinical performance and scalability, especially in countries with few ophthalmologists. Although research has been mainly conducted in Asia, there is a lack of research from Africa and low-income countries. Future techniques, including ensemble models and federated learning, will enhance accuracy and reliability further, aiding early diagnosis and prevention of vision loss globally.

糖尿病视网膜病变检测:AI模型和方法。
背景:糖尿病性视网膜病变(DR)是慢性糖尿病对视网膜血管的损害,是世界范围内视力丧失的主要原因。如果早期发现DR,可以预防视力丧失,但传统的视网膜筛查需要时间和专业知识。人工智能技术的最新进展,包括经典机器学习和深度学习,可以更准确地检测DR。本文提供了目前的人工智能模型和DR筛选方法的全面回顾。方法:检索PubMed、Web of Science、Scopus、ScienceDirect、EBSCOhost等关键词:糖尿病、视网膜病变、筛查、早期发现。搜索仅限于英语语言和2020年至2025年之间发表的研究。结果:研究结果表明,人工智能模型已经成为早期DR诊断的关键。虽然传统的机器学习以前缺乏有效性,但深度学习现在显着提高了诊断性能。这些模型,如URNet系统、视觉转换器(ViT)模型、ResNet-50和EfficientNetB0模型、DenseNet模型和ResNet-18模型,已经使用公开可用的数据集实现了高性能指标。DR筛选设备,如ADX-DR,已经显示出值得称道的性能。EyeArt模式在不同人群中表现出卓越的灵敏度,检测出约98.5%的视觉威胁DR,而谷歌AI在特异性上与专家表现相当,在灵敏度上超过了专家表现。结论:使用cnn等深度学习框架的人工智能方法在DR分类中已经达到了专家级的准确性,并且得到了现实世界的验证。IDx-DR和EyeArt等半自主系统具有强大的临床性能和可扩展性,特别是在眼科医生很少的国家。虽然研究主要在亚洲进行,但非洲和低收入国家缺乏研究。未来的技术,包括集成模型和联邦学习,将进一步提高准确性和可靠性,帮助全球早期诊断和预防视力丧失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ophthalmology
Journal of Ophthalmology MEDICINE, RESEARCH & EXPERIMENTAL-OPHTHALMOLOGY
CiteScore
4.30
自引率
5.30%
发文量
194
审稿时长
6-12 weeks
期刊介绍: Journal of Ophthalmology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the anatomy, physiology and diseases of the eye. Submissions should focus on new diagnostic and surgical techniques, instrument and therapy updates, as well as clinical trials and research findings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书